Priorix-Tetra inj. sol. (pwdr. + solv.) s.c./i.m. pre-filled syr. vial

Maa: Belgia

Kieli: englanti

Lähde: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktiivinen ainesosa:

Measles virus (live, attenuated) ; Mumps virus (live, attenuated) ; Rubella virus (live, attenuated) ; Varicella-zoster virus (live, attenuated)

Saatavilla:

GlaxoSmithKline Biologicals SA-NV

ATC-koodi:

J07BD54

INN (Kansainvälinen yleisnimi):

Measles Virus; Mumps virus; Rubella Virus; Varicella Virus

Lääkemuoto:

Powder and solvent for solution for injection

Koostumus:

Measles Virus; Mumps virus; Rubella Virus; Varicella Virus

Antoreitti:

Intramuscular use; Subcutaneous use

Terapeuttinen alue:

Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated

Tuoteyhteenveto:

CTI code: 303852-01 - Pack size: 1 dose + 2 x Injection needle + 0.5 ml - Commercialisation status: NO - FMD code: 05400571001058 - CNK code: 2469567 - Delivery mode: Medical prescription; CTI code: 303852-03 - Pack size: 1 dose + 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-02 - Pack size: 10 x 1 dose + 10 x 0.5 ml + 20 x Injection needle - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-05 - Pack size: 20 x 1 dose + 20 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-04 - Pack size: 10 x 1 dose + 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-06 - Pack size: 50 x 1 dose + 50 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Valtuutuksen tilan:

Commercialised: No

Valtuutus päivämäärä:

2007-10-08